- Metcela, a developer of regenerative biological products for heart failure treatment, raised $12.7M in a Series B round led by University of Tokyo Edge Capital. - J-Pharma, a Japanese clinical-stage biopharma company, raised $4.9M in a Series D round led by Eight Roads Ventures. - RIN Institute, which develops monoclonal antibodies for colorectal cancer diagnosis and treatment, raised $1.9M in a seed round led by UTokyo Innovation Platform.

1. TRACXN MONTHLY REPORT
JANUARY 2021
JAPAN TECH

2. Japan Tech - January 2021 Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Contents
2
Japan Tech Snapshot 3
Investment Snapshot 4
List of Funding Rounds 5
New Investors 6
Top Funded Business Models - last 1 year 7
New Analyst Picks 8
Acquisitions 9
Recent News 10

3. Japan Tech - January 2021 Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Japan Tech Snapshot – January 2021
Japan Tech: Snapshot – January 2021
Note : "Investors" refers to "Institutional Investors" only
3
$20.6M
2
Overall Geo Stats
2
1
11
5
4
Funding Rounds $ Invested Analyst Picks
Metcela Upgraded
to MINICORN
New Investors
Alfresa Holdings
Corporation
MAKOTO CAPITAL inc
Series A+ rounds Active Investors IPOs Acquisitions
Rigaku#@
Top Funding Rounds Top Markets Top Investors Top Cities
Monthly Leader Board
Kanagawa
(1 Rounds, $12.7M)
Yokohama
(1 Rounds, $4.9M)
Chuo
(1 Rounds, $1.9M)
Uji
(1 Rounds, $1.1M)
$12.7M - Series B
Metcela (2016, Kanagawa, $22.7M)
$4.9M - Series D
J-Pharma (2005, Yokohama, $21.2M)
$1.9M - Seed
RIN Institute (2016, Chuo, $1.9M)
$1.1M - Seed
Kyoto Fusioneering (2019, Uji, $3.3M)
University of Tokyo Edge
Capital
(1 Investments)
Dai-Ichi Life
(1 Investments)
Japan Lifeline
(1 Investments)
Alfresa Holdings
Corporation
(1 Investments)
Cardiac and Vascular Disorders
Metcela
Oncology
J-Pharma
Immunotherapy
RIN Institute
Diagnostics (by Technology)
Market Size
Companies Covered 4,424
Funded Companies 2,067
Total Funding $10.7B
Funding in last 12 months $1.3B
Top Exits
IPOs 489
Acquisitions 137
Company Stage
Unicorns 5
Soonicorns 33
Minicorns 133
Editor Picks 493
Series A+ 545
Series C+ 119
Acqui-Hires 1
Deadpooled 232
Top Cities
Tokyo (717 Rounds, $5.3B)
Minato (171 Rounds, $1.1B)
Top Investors
Mitsubishi UFJ Capital (115
Investments)
SMBC Venture Capital (83
Investments)

4. Japan Tech - January 2021 Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Investment Snapshot
Investment Snapshot of Japan Tech as of January 2021
Japan Tech: Investment Snapshot
4
# Rounds
$ Funding
Investment Trend Top Investments (January 2021)*
Metcela
(2016, Kanagawa, $22.7M)
$12.7M - Series B University of Tokyo Edge Capital
J-Pharma
(2005, Yokohama, $21.2M)
$4.9M - Series D Eight Roads Ventures
RIN Institute
(2016, Chuo, $1.9M)
$1.9M - Seed UTokyo Innovation Platform
Kyoto Fusioneering
(2019, Uji, $3.3M)
$1.1M - Seed Coral Capital
*Shows only the lead Investors

5. Japan Tech - January 2021 Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
List of Funding Rounds
List of Funding Rounds in Japan Tech in January 2021
Japan Tech: List of Funding Rounds
Note: Seed Stage (Seed, Angel), Early Stage (Series A, Series B), Late Stage (Series C+), PE
5
LATE STAGE
$4.9M - Series D
J-Pharma (2005, Yokohama, $21.2M)
Japanese, clinical stage biopharma company
developing therapeutics for Oncology and other
targets
Eight Roads Ventures, FPrime Capital Partners
EARLY STAGE
$12.7M - Series B
Metcela (2016, Kanagawa, $22.7M)
Developer of regenerative biological product for the
treatment of heart failure
University of Tokyo Edge Capital, MAKOTO CAPITAL
inc, Alfresa Holdings Corporation, Dai-Ichi Life, Sony
Innovation Fund, and 2 more
SEED STAGE
$1.1M - Seed
Kyoto Fusioneering (2019, Uji, $3.3M)
Provider of solutions for nuclear fusion
Coral Capital
SEED STAGE
$1.9M - Seed
RIN Institute (2016, Chuo, $1.9M)
Developer of monoclonal antibodies for the diagnosis
and treatment of colorectal cancer
UTokyo Innovation Platform

6. Japan Tech - January 2021 Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
New Investors
List of New Investors in Japan Tech in January 2021
Japan Tech: List of New Investors
6
Investor Company Info Round Amount Round Name
Alfresa Holdings Corporation
1 portfolio companies | Manufacture, import & export and wholesaling of drugs
and other healthcare products
Metcela
Developer of regenerative biological product for the treatment of heart
failure
$12.70M Series B
MAKOTO CAPITAL inc
1 portfolio companies |
Metcela
Developer of regenerative biological product for the treatment of heart
failure
$12.70M Series B

7. Japan Tech - January 2021 Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Top Funded Business Models - last 1 year
* Rank is based on $Invested in last 1 year in the Business Model. ▲- Indicates change in Rank from previous 1
year.
7
Rank Business Model $ Funding # Rounds Top Funding Round
1 ▲5 Self Driving Cars $92.3M 1 Tier Ⅳ | $92.3M | Series B
2 -- Lithium Ion Batteries $74.3M 2 APB | $74.3M | Series C
3 -- Construction Field Management Software $56.3M 2 Andpad | $37.4M | Series C
4 ▲48 Construction Operations Management Platform $56.3M 2 Andpad | $37.4M | Series C
5 ▲20 Construction Project Management Software $56.2M 2 ANDPAD | $37.3M | Series C
6 ▲14 NewSpace > Space Services > Space Debris > Removal $51.0M 2 Astroscale | $51.0M | Series E
7 ▼-3 Warehouse Automation $50.0M 1 Geek+ | $50.0M | Series C
8 ▼-3 Warehouse Automation Tools $50.0M 1 Geek+ | $50.0M | Series C
9 ▲26 Internet First Reloadable Prepaid Card Issuers $45.0M 1 Kyash | $45.0M | Series C
10 ▲17
Security & Surveillance Technology > PIAM > Secured
Entry Control > Smart Lock
$33.0M 1 Photosynth | $33.0M | Series C

8. Japan Tech - January 2021 Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
New Analyst Picks
Interesting Companies identified by Analysts in Japan Tech in January 2021
Japan Tech: Analyst Picks
8
Upgraded to MINICORN
Metcela (2016, Kanagawa, $12.7M, Series B)
Developer of regenerative biological product for the
treatment of heart failure
Eight Roads Ventures, University of Tokyo Edge Capital,
Kanagawa Science Park and 8 other Investors
Added to Editor's Pick
I & C Cruise (2008, Minato, $2.0M, Series A)
Offers customer acquisition services and among other
businesses
Energy & Environment Investment, Samurai Incubate,
Fenox Venture Capital and 2 other Investors
Added to Editor's Pick
SenSprout (2015, Minato, $1.3M, Series A)
Provider of cloud-based soil moisture sensor systems
Mitsui Sumitomo Insurance Venture Capital, Mitsui
Sumitomo Insurance, Chivas Venture and 3 other
Investors
Added to Editor's Pick
Go Go GS (2004, Kamakura, Unfunded)
Online platform offering fuel station discovery and fuel
price monitoring solutions
Added to Editor's Pick
RIN Institute (2016, Chuo, $1.9M, Seed)
Developer of monoclonal antibodies for the diagnosis
and treatment of colorectal cancer
UTokyo Innovation Platform,Fast Track Initiativeand

9. Japan Tech - January 2021 Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Acquisitions
List of Acquisitions in Japan Tech in January 2021
Japan Tech: Acquisitions
9
Acq. Date Company Acquirer Deal Size
06 Jan 2021
Rigaku(1951, Tokyo)
Provider of XRD, XRF, SAXS, Raman, metrology. and
crystallography solutions
The Carlyle Group

10. Japan Tech - January 2021 Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Recent News (1/2)
Recent News in Japan Tech in January 2021
Japan Tech:News
10
Exit News
.
● Fitness app "Keep" is considering the fastest IPO this year, with a valuation of
approximately US$2 billion 36Kr
.
● NEC's Northgate Public Services Acquires Charter Systems Ltd to Improve
Information Sharing for Undercover Policing ACN Newswire
.
● Carlyle to buy Japanese testing-tools maker Rigaku to help IPO pursuit Reuters
.
● NTT Data Acquires SAP Partner My Supply Chain Group (MSCG) ChannelE2E
.
● SoftBank's Masayoshi Son poised for another IPO windfall in 2021 The Straits
Times
.
● AbbVie dumps unwanted Sosei neuro pact from Allergan's past FierceBiotech
.
People News
.
● SoftBank names new mobile chief as Son steps back MobileWorldLive
.
● Dentsu Hong Kong promotes Simone Tam to CEO MARKETING-INTERACTIVE
.
Company News

11. Japan Tech - January 2021 Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Explore more on Tracxn
Explore more about Japan Tech on Tracxn Platform
Japan Tech: Explore more on Tracxn Platform
11
Companies
Recent Companies Covered
Funded Companies
Editor's Pick
Soonicorn Club
SaaS Companies in Japan
AI Companies in Japan
Fintech Companies Japan
Consumer Digital in Japan
Company Due Diligence
Detailed profile of JOLED
Competitors of Geek+
Cap Tables of Smart News
Investment Activity
Recent Investments
Investment Trend of last 10 years
Mega Investments Rounds
Investors
Most Active Investors
Most Active Angel Investors
Unicorn Investors
Exits
IPO'd Companies
Recent Acquisitions
Most Active Acquirers
Recent Acquihires
News & Events
Recent News
News on People
News on Unicorns
Upcoming Events
Library
Recent Reports
Tracxn Blog
Global Sector Landscape

12. Copyright © 2021, Tracxn Technologies Private Limited. All rights reserved.
Any and all information either accessed from the website www.tracxn.com or having otherwise originated from Tracxn Technologies Private Limited including but not limited to the
information contained herein ("Data") is the sole property of Tracxn Technologies Private Limited (hereinafter "Tracxn"). You shall not recirculate, distribute, transmit, publish, or sell the
Data or any portion thereof in any form or by any means, either for commercial or non-commercial use, or permit any third party to use or distribute the Data or any portion thereof; to any
other party, except with the prior written consent of Tracxn. You may however incorporate insubstantial portions, extracts, abstracts or summaries from the Data into analysis, presentations
or tools for your customers or for your internal use, so long as Tracxn is clearly and visibly identified as the source of information.
For further information please refer to our Terms of Use at www.tracxn.com